CN Stock MarketDetailed Quotes

688336 Sunshine Guojian Pharmaceutical

Watchlist
  • 23.49
  • -0.19-0.80%
Market Closed May 17 15:00 CST
14.49BMarket Cap41.14P/E (TTM)

Sunshine Guojian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sunshine Guojian Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

266.90M

+28.72%
EPS(YoY)

0.15

+200.00%
Analyst Rating

Buy

May 18, 2024

Sunshine Guojian Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.343B--
--2024/FY-- / 1.253B--
Mar 21, 20242023/FY1.014B / 959.690M--
Mar 22, 20232022/FY825.492M / 969.620M--
Mar 29, 20222021/FY928.807M / 1.147B--
--2020/FY655.006M / 865.050M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.343B--
--2024/FY-- / 1.253B--
Mar 21, 20242023/FY1.014B / 959.690M--
Mar 22, 20232022/FY825.492M / 969.620M--
Mar 29, 20222021/FY928.807M / 1.147B--
--2020/FY655.006M / 865.050M--
--------
--------
--------
--------

Unlock Free Earnings Estimates

Sunshine Guojian Pharmaceutical Earnings Reports

  • Sansei Guojian: Report for the first quarter of 2024

    Apr 25 12:00 ET

  • Kokuken Mitsubo: Summary of the 2023 Annual Report

    Mar 20 12:00 ET

  • Kokuken Mitsubo: Annual Report 2023

    Mar 20 12:00 ET

  • Sansei Guojian: 2023 Annual Results Report Announcement

    Feb 23 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 18, 2024

    Buy

    • Strong Buy

      25.00%

    • Buy

      75.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg